51 results
Page 2 of 3
6-K
EX-99.2
1u4namnz8ztn
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
kvudpgjbr2v
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-1.1
13cr0aocsuxjq7rrzhzn
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
i0kcpui8
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
0lxnpwjnd0qvokwd
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
vy6k5gy5 div
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
prx ba72uz
15 Jan 21
Prospectus supplement for primary offering
7:00am
6-K
EX-99.2
xz2t96srxhvlq b8
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
EX-10.1
sj4j eslut
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
b0u5y jy4vl
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-99.2
nqo5d
1 Nov 19
Current report (foreign)
4:15pm
6-K
EX-10.1
aepsy
17 May 19
Current report (foreign)
5:20pm
6-K
EX-99.2
l9cnokq20
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-1.1
4ufm7i
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am